Sun Pharmaceutical Industries Ltd has completed the $3.2 billion acquisition of Ranbaxy Laboratories Ltd on Wednesday. This merger will make Sun Pharma the largest pharmaceutical company in India with a market share of 9.2% and sales of $1.1 billion, as well as the world's fifth largest maker of generic drugs after Teva, Sandoz, Activas and Mylan.
Dilip Shanghvi, Sun Pharma managing director, said, "The merger has created a combined entity which has much more managerial capability. We will look to retain and nurture the talent. The company would invest more than $300 million (over Rs.1,800 crore) in research and development in 2015, which would be 6-7% of the combined revenue."
FDA Issues Recall of 200 Vials of Sun Pharma’s Chemo Drug
The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug.
Advertisement
Following the merger, Ranbaxy will be delisted from Indian stock exchanges, and each Ranbaxy shareholder will receive 0.8 share of Sun Pharma for each share of Ranbaxy.
The Punjab and Haryana High Court approved the merger earlier this month, while the US Federal Trade Commission (FTC) had approved the merger in January 2015. On March 23, the Competition Commission of India (CCI) had approved the Sun Pharmaceutical and Ranbaxy sale of seven brands to Emcure Pharma to comply with the conditional nod for their merger.
Source: Medindia
Source: Medindia
Sun Pharma Issues Recall for Two Drugs in US Market
Trouble deepened for Sun Pharmaceuticals after it was forced to recall over 4 lakh bottles of anti-depressant and anti-allergy drugs.
Advertisement
 Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nodun Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US FDA. | Advertisement
|
Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries
The Indian multinational pharmaceutical company, Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug, Synriam, in seven African countries.
Advertisement
Recommended Reading
Latest General Health News
Over 300 people had fallen sick with illness caused by Norovirus on a US cruise ship, say authorities.
Ex-smokers in Wakefield have shared their stories to encourage others to give up cigarettes on No Smoking Day 2023 which falls on 8th March.
Total levels of m6A in the nervous system rise with age and that (some) neurodegenerative diseases are characterized by RNA hypermethylation.
New study provides insights into the impact of early-life adversity on brain development and on control of reward behaviors that underlie emotional disorders
Ministry of Health of the Republic of Indonesia signed a formal memorandum of understanding (MOU) that will expand access to essential diagnostics in the country.